相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The impact of treatment adherence on clinical and economic outcomes in multiple sclerosis: Real world evidence from Alberta, Canada
Brittany Gerber et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)
Adherence to disease-modifying therapies and its impact on relapse, health resource utilization, and costs among patients with multiple sclerosis
Jack Burks et al.
CLINICOECONOMICS AND OUTCOMES RESEARCH (2017)
Multiple Sclerosis: Immunopathology and Treatment Update
Narges Dargahi et al.
BRAIN SCIENCES (2017)
Subcutaneous peginterferon β-1a injection-site reaction experience and mitigation: Delphi analysis of the ALLOW study
Barry Hendin et al.
NEURODEGENERATIVE DISEASE MANAGEMENT (2017)
COMPARE: Pharmacokinetic profiles of subcutaneous peginterferon beta-1a and subcutaneous interferon beta-1a over 2 weeks in healthy subjects
Xiao Hu et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Pharmacokinetics and pharmacodynamics of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis in the randomized ADVANCE study
Xiao Hu et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE
Bernd C. Kieseier et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Narrative Review of the Literature on Adherence to Disease-Modifying Therapies Among Patients with Multiple Sclerosis
Joseph Menzin et al.
JOURNAL OF MANAGED CARE PHARMACY (2013)
A Novel PEGylated Interferon Beta-1a for Multiple Sclerosis: Safety, Pharmacology, and Biology
Xiao Hu et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Cutaneous adverse events associated with disease-modifying treatment in multiple sclerosis: a systematic review
Deepak M. W. Balak et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
The prevalence of injection-site reactions with disease-modifying therapies and their effect on adherence in patients with multiple sclerosis: an observational study
Karsten Beer et al.
BMC NEUROLOGY (2011)
Dose titration of intramuscular interferon beta-1a reduces the severity and incidence of flu-like symptoms during treatment initiation
Mark A. Matson et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis
V. Devonshire et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Adherence to Disease-Modifying Therapies in Spanish Patients with Relapsing Multiple Sclerosis: Two-Year Interim Results of the Global Adherence Project
E. Arroyo et al.
EUROPEAN NEUROLOGY (2011)
Subcutaneous Interferon-β injections in patients with multiple sclerosis initiate inflammatory skin reactions by local chemokine induction
M Buttmann et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Randomized, comparative study of interferon β-1a treatment regimens in MS -: The EVIDENCE trial
H Panitch et al.
NEUROLOGY (2002)
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)
L Durelli et al.
LANCET (2002)
分享论文
